HK1211847A1 - Selection and use of lactic acid bacteria preventing bone loss in mammals - Google Patents

Selection and use of lactic acid bacteria preventing bone loss in mammals

Info

Publication number
HK1211847A1
HK1211847A1 HK15112740.1A HK15112740A HK1211847A1 HK 1211847 A1 HK1211847 A1 HK 1211847A1 HK 15112740 A HK15112740 A HK 15112740A HK 1211847 A1 HK1211847 A1 HK 1211847A1
Authority
HK
Hong Kong
Prior art keywords
mammals
selection
lactic acid
acid bacteria
bone loss
Prior art date
Application number
HK15112740.1A
Other languages
English (en)
Chinese (zh)
Inventor
埃蒙.康諾利
羅伯特.艾倫.布里頓
勞拉.雷.麥凱布
Original Assignee
Biogaia Ab
Univ Michigan State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab, Univ Michigan State filed Critical Biogaia Ab
Publication of HK1211847A1 publication Critical patent/HK1211847A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK15112740.1A 2012-06-04 2015-12-28 Selection and use of lactic acid bacteria preventing bone loss in mammals HK1211847A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261689338P 2012-06-04 2012-06-04
PCT/SE2013/050646 WO2013184064A1 (en) 2012-06-04 2013-06-04 Selection and use of lactic acid bacteria preventing bone loss in mammals

Publications (1)

Publication Number Publication Date
HK1211847A1 true HK1211847A1 (en) 2016-06-03

Family

ID=49712339

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112740.1A HK1211847A1 (en) 2012-06-04 2015-12-28 Selection and use of lactic acid bacteria preventing bone loss in mammals

Country Status (17)

Country Link
US (4) US20150150917A1 (xx)
EP (2) EP3456334B1 (xx)
JP (1) JP6193981B2 (xx)
KR (2) KR102191537B1 (xx)
CN (1) CN104755091B (xx)
AU (2) AU2013272330B2 (xx)
CA (1) CA2875841C (xx)
DK (2) DK2854826T3 (xx)
ES (2) ES2711427T3 (xx)
HK (1) HK1211847A1 (xx)
HR (1) HRP20190162T1 (xx)
HU (1) HUE042643T2 (xx)
LT (1) LT2854826T (xx)
PL (2) PL2854826T3 (xx)
SI (1) SI2854826T1 (xx)
TR (1) TR201901771T4 (xx)
WO (1) WO2013184064A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101915904B1 (ko) * 2016-08-12 2018-11-06 한국식품연구원 락토바실러스 인테스티날리스를 포함하는 갱년기 예방 또는 치료용 조성물
KR102120479B1 (ko) * 2018-10-30 2020-06-09 주식회사 종근당바이오 프로바이오틱스를 유효 성분으로 포함하는 이차성 골다공증의 예방 또는 치료용 조성물
US20220125860A1 (en) * 2019-02-05 2022-04-28 Elanco Us Inc. Probiotic compositions comprising lactobacillus reuteri strains and methods of use
KR102080498B1 (ko) * 2019-08-23 2020-02-24 정영옥 페룰산 및 유산균을 유효성분으로 포함하는 골감소증 개선 또는 예방용 식품 조성물
JPWO2021112041A1 (xx) * 2019-12-02 2021-06-10
CN111718903A (zh) * 2020-06-24 2020-09-29 江南大学 一种筛选可预防和/或治疗骨质疏松的药物的方法
CN114711429B (zh) * 2021-06-08 2023-11-17 青岛蔚蓝生物股份有限公司 一株具有增强骨健康作用的罗伊氏乳杆菌及其应用
CN114634901B (zh) * 2022-05-18 2022-08-30 微康益生菌(苏州)股份有限公司 一种促进骨骼健康的干酪乳杆菌lc16及其培养方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005537236A (ja) * 2002-06-13 2005-12-08 ユニバーシティ・カレッジ・コークーナショナル・ユニバーシティ・オブ・アイルランド,コーク プロバイオティック治療
US7344867B2 (en) * 2005-04-15 2008-03-18 Eamonn Connolly Selection and use of lactic acid bacteria for reducing inflammation in mammals
EP2604689B1 (en) 2005-07-26 2015-01-21 Nestec Ltd. Anti-obesity agent and anti-obesity food
CA2662710A1 (en) * 2006-09-07 2008-03-13 Mcgill University Oral polymeric membrane feruloyl esterase producing bacteria formulation
US20080254011A1 (en) * 2007-04-11 2008-10-16 Peter Rothschild Use of selected lactic acid bacteria for reducing atherosclerosis

Also Published As

Publication number Publication date
EP3456334A1 (en) 2019-03-20
JP6193981B2 (ja) 2017-09-06
CN104755091A (zh) 2015-07-01
DK3456334T3 (da) 2021-01-25
TR201901771T4 (tr) 2019-03-21
EP2854826A1 (en) 2015-04-08
HRP20190162T1 (hr) 2019-04-05
PL2854826T3 (pl) 2019-06-28
EP2854826B1 (en) 2018-11-14
PL3456334T3 (pl) 2021-05-04
US20180200313A1 (en) 2018-07-19
AU2013272330A1 (en) 2015-01-15
EP2854826B9 (en) 2019-05-08
CN104755091B (zh) 2020-07-21
US9968643B2 (en) 2018-05-15
CA2875841A1 (en) 2013-12-12
KR20200044134A (ko) 2020-04-28
ES2711427T8 (es) 2019-06-20
CA2875841C (en) 2021-02-02
HUE042643T2 (hu) 2019-07-29
DK2854826T3 (en) 2019-03-11
EP2854826A4 (en) 2016-07-06
SI2854826T1 (sl) 2019-03-29
JP2015526389A (ja) 2015-09-10
EP3456334B1 (en) 2020-11-11
US20170128501A1 (en) 2017-05-11
WO2013184064A1 (en) 2013-12-12
US20190142879A1 (en) 2019-05-16
LT2854826T (lt) 2019-02-11
AU2018200524B2 (en) 2019-07-18
AU2013272330B2 (en) 2017-11-02
US20150150917A1 (en) 2015-06-04
US10537598B2 (en) 2020-01-21
KR102191537B1 (ko) 2020-12-16
US10232001B2 (en) 2019-03-19
KR20150028968A (ko) 2015-03-17
AU2018200524A1 (en) 2018-02-15
ES2711427T3 (es) 2019-05-03
ES2847424T3 (es) 2021-08-03

Similar Documents

Publication Publication Date Title
HRP20190162T1 (hr) Lactobacillus reuteri atcc pta 6475 za uporabu za sprječavanje ili liječenje gubitka kosti kod sisavaca
HK1245130A1 (zh) 酶組合物及其用於創傷愈合的用途
HK1191671A1 (zh) 乾燥乳酸菌和新的組合物
PL2685994T3 (pl) Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie
HK1212387A1 (en) Lactic acid bacteria capable of preventing and or treating senescence and dementia
HK1218836A1 (zh) 協同細菌組合物和其製造方法和用途
HK1203367A1 (en) Medical organogel processes and compositions
ZA201300612B (en) Novel bacteria and methods of use thereof
EP2811897A4 (en) MEDICAL TERMINAL AND APPLICATION METHOD
PT2771041T (pt) Composições e suas utilizações na cicatrização óssea
EP2925203A4 (en) SMOOTH AND VOLUMINOUS FABRIC
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
ZA201405858B (en) Recombinant microorganisms and methods of use thereof
EP2659898A4 (en) MEANS FOR CREATING INTERFERON PRODUCTION WITH MILK ACID BACTERIA
AP2013007123A0 (en) Asymmetric ureas and medical uses thereof
EP2814413A4 (en) BONE FIXING ELEMENT AND METHODS OF USE
EP2822627A4 (en) STERILIZATION AND HUMIDIFICATION APPARATUS AND INCUBATOR
EP2603221A4 (en) GGF2 AND METHODS OF USE
SG11201504153QA (en) Beverage with heart aid functional ingredients and process thereof
EP2814412A4 (en) BONE FIXING ELEMENT AND METHODS OF USE
EP2670438A4 (en) SELECTION AND TREATMENT OF PATIENTS
HK1196535A1 (zh) 鹽及醫藥用途
EP2896294A4 (en) MICRORNA IN HUMAN MILK AND USE THEREOF
EP2900166A4 (en) STERILIZATION CONTAINER AND METHOD OF ORGANIZATION
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment